Detalhe da pesquisa
1.
Liver steatosis in patients with transfusion-dependent thalassaemia.
Br J Haematol
; 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38685724
2.
Hearing loss in beta-thalassaemia: An Italian multicentre case-control study.
Br J Haematol
; 204(5): 2016-2024, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38500389
3.
Impact of genotype on multi-organ iron and complications in patients with non-transfusion-dependent ß-thalassemia intermedia.
Ann Hematol
; 103(6): 1887-1896, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38581547
4.
Pancreatic iron in pediatric transfusion-dependent beta-thalassemia patients: A longitudinal MRI study.
Pediatr Blood Cancer
; 71(5): e30923, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38385860
5.
Multiparametric cardiac magnetic resonance in patients with thalassemia intermedia: new insights from the E-MIOT network.
Radiol Med
; 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38683500
6.
Liver fibrosis in young patients with transfusion-dependent thalassaemia (TDT), understanding the role of steatosis.
Br J Haematol
; 200(4): 399-400, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36301125
7.
Development of a Thalassemia International Prognostic Scoring System (TIPSS).
Blood Cells Mol Dis
; 99: 102710, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36463683
8.
Prognostic value of multiparametric cardiac magnetic resonance in sickle cell patients.
Ann Hematol
; 102(2): 261-270, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36459182
9.
Primary HBB gene mutation severity and long-term outcomes in a global cohort of ß-thalassaemia.
Br J Haematol
; 196(2): 414-423, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34697800
10.
A complication risk score to evaluate clinical severity of thalassaemia syndromes.
Br J Haematol
; 192(3): 626-633, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33216983
11.
Longitudinal follow-up of patients with thalassaemia intermedia who started transfusion therapy in adulthood: a cohort study.
Br J Haematol
; 191(1): 107-114, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32427352
12.
Red blood cell consumption in a large cohort of patients with thalassaemia: a retrospective analysis of main predictors.
Ann Hematol
; 99(6): 1209-1215, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32363417
13.
Urinary Metabolic Profile of Patients with Transfusion-Dependent ß-Thalassemia Major Undergoing Deferasirox Therapy.
Kidney Blood Press Res
; 45(3): 455-466, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32434200
14.
Prevalence of extramedullary hematopoiesis, renal cysts, splenic and hepatic lesions, and vertebral hemangiomas among thalassemic patients: a retrospective study from the Myocardial Iron Overload in Thalassemia (MIOT) network.
Ann Hematol
; 98(6): 1333-1339, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30891614
15.
The impact of liver steatosis on the ability of serum ferritin levels to be predictive of liver iron concentration in non-transfusion-dependent thalassaemia patients.
Br J Haematol
; 180(5): 721-726, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29363758
16.
MRI multicentre prospective survey in thalassaemia major patients treated with deferasirox versus deferiprone and desferrioxamine.
Br J Haematol
; 183(5): 783-795, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30334574
17.
The effect of desferrioxamine chelation versus no therapy in patients with non transfusion-dependent thalassaemia: a multicenter prospective comparison from the MIOT network.
Ann Hematol
; 97(10): 1925-1932, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29926157
18.
The unexpected impact of cabozantinib on red blood cells consumption in patients with transfusion-dependent thalassemia.
Ann Hematol
; 101(7): 1621-1623, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35246730
19.
Soluble form of transferrin receptor-1 level is associated with the age at first diagnosis and the risk of therapeutic intervention and iron overloading in patients with non-transfusion-dependent thalassemia.
Ann Hematol
; 96(9): 1541-1546, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28707012
20.
Risk of mortality from anemia and iron overload in nontransfusion-dependent ß-thalassemia.
Am J Hematol
; 97(2): E78-E80, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34862982